IPO registrations (S-1, F-1) · Registrants
AVALON PHARMACEUTICALS INC
- SEC CIK
- 1162192 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2005-05-03, last 2006-04-07; 2 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2005-09-29; declared effective 2006-12-19
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 20358 SENECA MEADOWS PARKWAY, Germantown, MD 20876
- EIN
- 52-2209310
- EDGAR entity type
- operating
- Insiders and CEO pay
- AVALON PHARMACEUTICALS INC on the corporate pages
Offering terms
- Proposed price range
- $10.00–$12.00 per share (S-1/A filed 2005-09-22)
- Final price
- $10.50 per share, within the range (424B4 filed 2005-09-29, an initial public offering)
- Shares sold
- 2,750,000
- Gross proceeds
- $28,875,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol AVRX
- Lead underwriters
- Short-term marketable securities (1,103,639 shares)
- Syndicate
- Nasdaq National Market and the; Legg Mason; Susquehanna Financial Group; Accounts receivable (487,846); Interest receivable (82,905); Deposits (102,046)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Lobbying client: AVALON PHARMACEUTICALS Fuzzy (name and state)
- SEC filer: AVALON PHARMACEUTICALS INC EXACT (CIK (EXACT))
- Person page: C Eric Winzer Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
- Person page: Kenneth C Carter Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer))
Filings 13
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2005-05-03 | S-1 | S-1 (registration) | AVALON PHARMACEUTICALS INC | 0000950133-05-001884 ↗ |
| 2005-06-23 | S-1/A | S-1/A (amendment) | AVALON PHARMACEUTICALS INC | 0000950133-05-002776 ↗ |
| 2005-08-18 | S-1/A | S-1/A (amendment) | AVALON PHARMACEUTICALS INC | 0000950133-05-003815 ↗ |
| 2005-09-01 | S-1/A | S-1/A (amendment) | AVALON PHARMACEUTICALS INC | 0000950133-05-004019 ↗ |
| 2005-09-09 | S-1/A | S-1/A (amendment) | AVALON PHARMACEUTICALS INC | 0000950133-05-004101 ↗ |
| 2005-09-14 | S-1/A | S-1/A (amendment) | AVALON PHARMACEUTICALS INC | 0000950133-05-004153 ↗ |
| 2005-09-22 | S-1/A | S-1/A (amendment) | AVALON PHARMACEUTICALS INC | 0000950133-05-004258 ↗ |
| 2005-09-29 | 424B4 | 424B4 (final prospectus) | AVALON PHARMACEUTICALS INC | 0000950133-05-004409 ↗ |
| 2006-04-07 | S-1 | S-1 (registration) | AVALON PHARMACEUTICALS INC | 0000950133-06-001728 ↗ |
| 2006-12-19 | EFFECT | EFFECT (declared effective) | AVALON PHARMACEUTICALS INC | 9999999995-06-002768 ↗ |
| 2007-02-07 | EFFECT | EFFECT (declared effective) | AVALON PHARMACEUTICALS INC | 9999999995-07-000514 ↗ |
| 2007-06-25 | EFFECT | EFFECT (declared effective) | AVALON PHARMACEUTICALS INC | 9999999995-07-002530 ↗ |
| 2007-11-13 | EFFECT | EFFECT (declared effective) | AVALON PHARMACEUTICALS INC | 9999999995-07-004504 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2005-09-22 | S-1/A | registration statement | $10.00–$12.00 | 2,750,000 | - | Nasdaq AVRX | 6 | primary document; range, shares headline, underwriting table 4, cover names 2 | document ↗ | |
| 2005-09-29 | 424B4 | final prospectus | $10.50 | 2,750,000 | $28,875,000 | 7 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ROYSTON IVOR | Director | 12 | 2006–2008 | ||
| WALTON ALAN G | Director; Director,TenPercentOwner | 11 | 2006–2008 | ||
| Whitaker Raymond J | Director | 8 | 2006–2007 | ||
| SCOTT WILLIAM A | Director | 4 | 2006–2008 | ||
| WASHECKA WILLIAM H | Director | 5 | 2006–2008 | ||
| Kurman Michael R | Director | 4 | 2006–2008 | ||
| Farmer Glen A | Officer | Principal Accounting Officer | 3 | 2006–2008 | |
| Hamilton J Michael | Officer | Chief Medical Officer | 4 | 2006–2009 | |
| Carter Kenneth C | Director,Officer | President and CEO | 7 | 2006–2009 | person page Fuzzy |
| LORIMIER BRADLEY G | Director | 6 | 2006–2009 | ||
| Muth David | Officer | EVP & Chief Business Officer | 2 | 2006 | |
| KABAKOFF DAVID S | Director | 5 | 2006–2008 | ||
| Bol David K | Officer | VP Pharmaceutical Development | 1 | 2006 | |
| David Thomas G | Officer | General Counsel & Sr VP Oper. | 1 | 2006 | |
| Lessing Gary | Officer | Chief Financial Officer | 1 | 2006 | |
| WINZER C ERIC | Officer | EVP & Chief Financial Officer | 3 | 2007–2008 | person page Fuzzy |
| Horrigan Stephen K | Officer | VP of Research | 2 | 2007–2008 | |
| Frost Philip | Director | 3 | 2008 | ||
| CLINICAL DATA INC | TenPercentOwner | 1 | 2008 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Lobbying client | AVALON PHARMACEUTICALS | MD | Federal lobbying (LDA) | name and state |
| SEC filer | AVALON PHARMACEUTICALS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | C Eric Winzer | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) | |
| Person page | Kenneth C Carter | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, MD first:
- NORTHWEST BIOTHERAPEUTICS INC MD
- UNITED THERAPEUTICS Corp MD
- INTERCELL USA, INC. MD
- MACROGENICS INC MD
- MiddleBrook Pharmaceuticals, Inc. MD
- IGC Pharma, Inc. MD
- CNBX Pharmaceuticals Inc. MD
- PRECIGEN, INC. MD
- SUPERNUS PHARMACEUTICALS, INC. MD
- Sucampo Pharmaceuticals, Inc. MD
In other datasets, the same topic (Health) in MD:
- Nonprofit: 4K FOR CANCER INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health